Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on May 14, 2014 and accepted by EDGAR at May 14, 2014, 08:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-01-01 to 2014-03-31 | $240.2k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-01-01 to 2014-03-31 | $102.9k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-01-01 to 2014-03-31 | $137.3k | us-gaap:GrossProfit |
| Operating income | 3 months2014-01-01 to 2014-03-31 | −$135.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-01-01 to 2014-03-31 | −$3.5k | us-gaap:InterestExpense |
| Net income | 3 months2014-01-01 to 2014-03-31 | −$161.6k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted shares (weighted) | 3 months2014-01-01 to 2014-03-31 | 25,044,056 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2014-01-01 to 2014-03-31 | $2.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2014-01-01 to 2014-03-31 | −$2.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
Source: SEC EDGAR, the filing index for accession 0001211524-14-000053. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.